Kratom, often referred to as "Mitragyna speciosa," is a plant native to Southeast Asia that has gained popularity in the United States as a supplement or herbal remedy. Its detection time in breastmilk may vary depending on factors such as the individual's usage patterns, dietary habits, and other medications they may be taking.
Detection Time
The estimated detection rate of kratom in breastmilk according to a study conducted in 2018 is 0.28%. This study found that the mean amount of Mitragynine in breastmilk was 93 ng/mL. However, it is important to note that a positive result does not necessarily confirm actual kratom exposure, as false positives can occur due to cross-reactions with other compounds.
Factors Influencing Detection Time
Usage Patterns
Regular, high-dose kratom use is associated with Kratom detection in breastmilk. Those who take larger amounts, particularly in a short period, could have detectable levels of Kratom in their breastmilk for a few days to a week.
Dietary Habits
Consumption of large meals, particularly high-fat ones, could potentially result in quicker detection of Kratom in breastmilk because of the fat-soluble nature of mitragynine. Taking kratom on an empty stomach could yield shorter detection times, as it is metabolized more quickly. Additionally, dehydration can increase the amount of mitragynine残留于体内。
Medications
Individuals who are on certain medications, especially those that are known to cause drug interactions, may have their kratom detection time affected. Specifically, reports of kratom detection in breastmilk have been observed in women who take medications for chronic pain, such as oxycodone.
##Kratom can be detected in breastmilk for up to 9 days, but detection times range widely based on the individual's unique factors. While this may present concerns for breastfeeding mothers, it is essential to remember that kratom is also found in many consumer products, and false positive tests are possible. More research is needed to support the findings of this study, and healthcare professionals should always advise mothers to discuss their medication history with their healthcare provider. Additionally, it is crucial for clinicians to recognize the potential for Kratom exposure in their patients and to be prepared to discuss management strategies, including weaning off kratom, with mothers who suspect their infant may be exposed.
